Trial intelligence / Profile preview

CPT-SMART for Treatment of PTSD and Cigarette Smoking

NCT03978442Phase 4Completed

Sponsor
VA Office of Research & Development
Start
Nov 2019
Primary completion
Oct 2025
Countries
1
01

Overview

Phase 4, randomised, open-label trial in Tobacco Use Disorder (TUD) and post-traumatic stress disorder (PTSD) (2 arms), sponsored by VA Office of Research & Development. Primary endpoint: Number of Participants Whose Self-report of 7 Day Point Prevalence Abstinence From Smoking is Bioverified at 6 months. Started Nov 2019; status: completed.

02

Conditions

Tobacco Use Disorder (TUD)post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT03978442.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03978442.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call